ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 179 filers reported holding ARGENX SE in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $76,694 | +36.7% | 156 | +8.3% | 0.01% | +50.0% |
Q2 2023 | $56,121 | +8.4% | 144 | +3.6% | 0.01% | 0.0% |
Q1 2023 | $51,789 | -7.0% | 139 | -5.4% | 0.01% | -14.3% |
Q4 2022 | $55,688 | -0.6% | 147 | -7.5% | 0.01% | -22.2% |
Q3 2022 | $56,000 | +1.8% | 159 | +10.4% | 0.01% | 0.0% |
Q2 2022 | $55,000 | +61.8% | 144 | +32.1% | 0.01% | +80.0% |
Q1 2022 | $34,000 | -37.0% | 109 | -29.7% | 0.01% | -37.5% |
Q4 2021 | $54,000 | +35.0% | 155 | +18.3% | 0.01% | -20.0% |
Q3 2021 | $40,000 | +33.3% | 131 | +31.0% | 0.01% | +42.9% |
Q2 2021 | $30,000 | +20.0% | 100 | +8.7% | 0.01% | +16.7% |
Q1 2021 | $25,000 | +8.7% | 92 | +16.5% | 0.01% | 0.0% |
Q4 2020 | $23,000 | +35.3% | 79 | +21.5% | 0.01% | +20.0% |
Q3 2020 | $17,000 | +54.5% | 65 | +38.3% | 0.01% | +66.7% |
Q2 2020 | $11,000 | +83.3% | 47 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $6,000 | 0.0% | 47 | +20.5% | 0.00% | 0.0% |
Q4 2019 | $6,000 | +50.0% | 39 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $4,000 | -20.0% | 39 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $5,000 | +25.0% | 39 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $4,000 | – | 39 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |